Breaking News

PSI CRO Appoints Regulatory Affairs Head

By Kristin Brooks | February 26, 2014

Schmoetzer brings extensive industry experience

Dr. Gabriele Schmoetzer has been appointed head of regulatory affairs, Germany, at PSI CRO. Dr. Schmoetzer will supervise all regulatory-related activities for Germany, Austria and Switzerland.
 
Dr. Schmoetzer brings 24 years of clinical research experience, having worked for small, mid-size and large CROs. She has held positions in international and global project management, regulatory affairs, where she has held managerial positions, and has been responsible for clinical trial submissions in Germany and a number of other EU countries. Dr. Schmoetzer has experience with RA-specific processes and brings both technical expertise and extensive knowledge of the clinical trial regulatory environment.
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Solid Dispersions

    Solid Dispersions

    Robert Harris, Juniper Pharma Services||April 5, 2016
    A universal formulation strategy for poorly soluble drugs?

  • Developing Palatable Drug Products

    Developing Palatable Drug Products

    Jeff Worthington and David Tisi, Senopsys LLC||March 9, 2016
    A decision framework and guide for CDMOs